About the journal
Cancer Microenvironment is a journal published by Springer Science+Business Media in Netherlands. It is listed in PUBMED according to the sources read. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Springer Science+Business Media
- ISSN
- 1875-2292 · 1875-2284
- Country
- Netherlands
- Access
- Not open access / not declared
- Declared peer-review model
- peer_review
- Official website
- https://www.springer.com/journal/12307
Index listings
- PUBMED · 2010-01-26
- Indexing
- PUBMED
- APC
- —
- Declared review time (DOAJ)
- —
- Activity (OpenAlex)
- Dormant — no works recorded since 2019
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Works in OpenAlex
232
Last recorded publication year
2019
h-index
59
i10-index
197
From OpenAlex open data (CC0).
Editorial & policy5
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2020
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 0%
- ORCID iDs in current deposits
- 0%
Identity & continuity1
- Source type
- journal
Classification(no data)
No data available to the platform for this group
No platform data for: Classification — absence is not a judgment about the journal.
Subject areas
- Cancer Cells and Metastasis
- Cancer Cells and Metastasis
- Immune cells in cancer
- Immune cells in cancer
- Cancer Immunotherapy and Biomarkers
- Cancer Immunotherapy and Biomarkers
- Immune Cell Function and Interaction
- Immune Cell Function and Interaction
Show all subjects (50)
- Immunotherapy and Immune Responses
- Immunotherapy and Immune Responses
- Cell Adhesion Molecules Research
- Cell Adhesion Molecules Research
- Cancer Research and Treatments
- Cancer Research and Treatments
- Chemokine receptors and signaling
- Cancer, Hypoxia, and Metabolism
- Cancer, Hypoxia, and Metabolism
- Chemokine receptors and signaling
- Peptidase Inhibition and Analysis
- MicroRNA in disease regulation
- Peptidase Inhibition and Analysis
- MicroRNA in disease regulation
- Angiogenesis and VEGF in Cancer
- Angiogenesis and VEGF in Cancer
- Epigenetics and DNA Methylation
- Epigenetics and DNA Methylation
- Cancer-related molecular mechanisms research
- Protease and Inhibitor Mechanisms
- Immune Response and Inflammation
- Protease and Inhibitor Mechanisms
- Cancer-related molecular mechanisms research
- Immune Response and Inflammation
- Cancer Genomics and Diagnostics
- Cancer Genomics and Diagnostics
- Mesenchymal stem cell research
- Pancreatic and Hepatic Oncology Research
- T-cell and B-cell Immunology
- Pancreatic and Hepatic Oncology Research
- T-cell and B-cell Immunology
- Mesenchymal stem cell research
- Cytokine Signaling Pathways and Interactions
- Extracellular vesicles in disease
- Prostate Cancer Treatment and Research
- Bone health and treatments
- Multiple Myeloma Research and Treatments
- Prostate Cancer Treatment and Research
- Bone health and treatments
- Multiple Myeloma Research and Treatments
- Extracellular vesicles in disease
- Cytokine Signaling Pathways and Interactions
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ